Cargando…

A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes

INTRODUCTION: Patients with type 2 diabetes (T2D) in Japan are prescribed a lower dose of metformin that their counterparts in Western countries due to concerns for the risk of lactic acidosis incidence. Here we report our study on the association between high-dose metformin administration and the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Yoshio, Kazumori, Kiyoyasu, Takeshima, Tomomi, Iwasaki, Kosuke, Tanaka, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994465/
https://www.ncbi.nlm.nih.gov/pubmed/33677755
http://dx.doi.org/10.1007/s13300-021-01029-7
_version_ 1783669760065536000
author Nagai, Yoshio
Kazumori, Kiyoyasu
Takeshima, Tomomi
Iwasaki, Kosuke
Tanaka, Yasushi
author_facet Nagai, Yoshio
Kazumori, Kiyoyasu
Takeshima, Tomomi
Iwasaki, Kosuke
Tanaka, Yasushi
author_sort Nagai, Yoshio
collection PubMed
description INTRODUCTION: Patients with type 2 diabetes (T2D) in Japan are prescribed a lower dose of metformin that their counterparts in Western countries due to concerns for the risk of lactic acidosis incidence. Here we report our study on the association between high-dose metformin administration and the incidence of lactic acidosis in Japanese patients with T2D. METHODS: A Japanese claims database (April 2008–November 2018) was analyzed. Factors associated with the incidence of lactic acidosis were first identified from the database records by conducting a case–control study, and these were then used as confounding factors in subsequent analyses. The association between high-dose metformin administration (≥ 1000 mg/day) and the incidence of lactic acidosis was compared with that between low-dose metformin (< 1000 mg/day) or no metformin administration and lactic acidosis incidence by using the following approaches: a logistic regression analysis hypothesizing that metformin-associated lactic acidosis is short term; a time-dependent proportional hazard model hypothesizing that the influence of metformin is cumulative; and a case–control study in which lactic acidosis incidence was the case and metformin administration within 3 months prior to the incidence of lactic acidosis (or corresponding date for the control) was the exposure. RESULTS: Prescriptions for biguanide and vitamin B complex and volume depletion were identified as factors associated with the incidence of lactic acidosis. The incidence rate was higher in patients prescribed metformin than in those not receiving metformin; however, it was not higher in those prescribed high-dose metformin compared to those prescribed low-dose metformin. The estimated regression coefficient for high-dose metformin administration was 0.816 (p < 0.001); this was not higher than those for low-dose metformin (1.047), vitamin B complex (2.725) and volume depletion (3.301). The time-dependent proportional hazard analysis did not indicate any effect of metformin prescription. CONCLUSION: The results suggest an association between metformin administration and the incidence of lactic acidosis, but an increase in the incidence rate of lactic acidosis was not observed in those patients receiving high-dose metformin compared to those receiving low-dose metformin. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-021-01029-7.
format Online
Article
Text
id pubmed-7994465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-79944652021-04-16 A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes Nagai, Yoshio Kazumori, Kiyoyasu Takeshima, Tomomi Iwasaki, Kosuke Tanaka, Yasushi Diabetes Ther Original Research INTRODUCTION: Patients with type 2 diabetes (T2D) in Japan are prescribed a lower dose of metformin that their counterparts in Western countries due to concerns for the risk of lactic acidosis incidence. Here we report our study on the association between high-dose metformin administration and the incidence of lactic acidosis in Japanese patients with T2D. METHODS: A Japanese claims database (April 2008–November 2018) was analyzed. Factors associated with the incidence of lactic acidosis were first identified from the database records by conducting a case–control study, and these were then used as confounding factors in subsequent analyses. The association between high-dose metformin administration (≥ 1000 mg/day) and the incidence of lactic acidosis was compared with that between low-dose metformin (< 1000 mg/day) or no metformin administration and lactic acidosis incidence by using the following approaches: a logistic regression analysis hypothesizing that metformin-associated lactic acidosis is short term; a time-dependent proportional hazard model hypothesizing that the influence of metformin is cumulative; and a case–control study in which lactic acidosis incidence was the case and metformin administration within 3 months prior to the incidence of lactic acidosis (or corresponding date for the control) was the exposure. RESULTS: Prescriptions for biguanide and vitamin B complex and volume depletion were identified as factors associated with the incidence of lactic acidosis. The incidence rate was higher in patients prescribed metformin than in those not receiving metformin; however, it was not higher in those prescribed high-dose metformin compared to those prescribed low-dose metformin. The estimated regression coefficient for high-dose metformin administration was 0.816 (p < 0.001); this was not higher than those for low-dose metformin (1.047), vitamin B complex (2.725) and volume depletion (3.301). The time-dependent proportional hazard analysis did not indicate any effect of metformin prescription. CONCLUSION: The results suggest an association between metformin administration and the incidence of lactic acidosis, but an increase in the incidence rate of lactic acidosis was not observed in those patients receiving high-dose metformin compared to those receiving low-dose metformin. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-021-01029-7. Springer Healthcare 2021-03-07 2021-04 /pmc/articles/PMC7994465/ /pubmed/33677755 http://dx.doi.org/10.1007/s13300-021-01029-7 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Nagai, Yoshio
Kazumori, Kiyoyasu
Takeshima, Tomomi
Iwasaki, Kosuke
Tanaka, Yasushi
A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
title A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
title_full A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
title_fullStr A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
title_full_unstemmed A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
title_short A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
title_sort claims database analysis of dose-dependency of metformin and incidence of lactic acidosis in japanese patients with type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994465/
https://www.ncbi.nlm.nih.gov/pubmed/33677755
http://dx.doi.org/10.1007/s13300-021-01029-7
work_keys_str_mv AT nagaiyoshio aclaimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT kazumorikiyoyasu aclaimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT takeshimatomomi aclaimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT iwasakikosuke aclaimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT tanakayasushi aclaimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT nagaiyoshio claimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT kazumorikiyoyasu claimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT takeshimatomomi claimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT iwasakikosuke claimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes
AT tanakayasushi claimsdatabaseanalysisofdosedependencyofmetforminandincidenceoflacticacidosisinjapanesepatientswithtype2diabetes